About this trial
Natural Orifice Specimen Extraction (NOSE) eliminates the need for additional abdominal incisions in minimally invasive colorectal procedures, potentially reducing the risk of wound complications and postoperative pain. In the context of restorative Total Mesorectal Excision (TME), single-stapling (SS) techniques facilitate NOSE through transanal rectal transection, as opposed to the conventional double-stapling technique. This study aims to explore the potential advantages of NOSE combined with SS anastomosis compared to conventional abdominal extraction in minimally invasive restorative TME.
Eligibility criteria
Qualifiers
Adult patients aged more than 18 years old at the time of surgery
Patients with a histological diagnosis of rectal adenocarcinoma
Patients who underwent surgery between January 2017 and January 2023
Patients with a low rectal tumor meeting the Low Rectal Cancer Development Programme (LOREC) criteria
Disqualifiers
Patients who underwent non-restorative procedures (including abdominoperineal resection or Hartmann's procedures).
Patients who underwent immediate or delayed coloanal anastomosis.
Patients who underwent open surgery.
Patients who underwent unplanned conversion from minimally invasive to open approach.
Trial design
Treatments tested in this trial
- Not listed